Light mask may soothe dry eyes in Graves' patients

NCT ID NCT07332988

ENROLLING_BY_INVITATION Symptom relief Sponsor: Grigore T. Popa University of Medicine and Pharmacy Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a low-level light therapy mask for dry eye disease in people with Graves' eye disease who haven't improved with standard treatments. Thirty adults will receive either the real light therapy or a sham device. The goal is to see if the treatment improves tear film stability and reduces symptoms over three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Low-level light therapy (LLLT) via a periocular mask
What this could lead to: If it works, this could offer a non-drug option to ease dry eye symptoms in people with Graves' disease who haven't gotten relief from standard treatments.
What could go wrong: This is a small early study with only 30 people. The sham device still gives 30% power, so the real effect may be small. Results may not apply to everyone with dry eye.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome endocrine exophthalmos Graves Ophthalmopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE DISEASE (DED) GRAVES OPHTHALMOPATHY

Contacts and locations

Locations

University of Medicine and Pharmacy "Grigore T. Popa"

Iași, Iaşi, 700115, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.